Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
MAPS, Sunstone Therapies Collaborate on MDMA Therapy Trial
09/19/2022
MAPS is collaborating with Sunstone Therapies to conduct a clinical trial testing the safety and tolerability of MDMA-assisted therapy for patients with treatment-resistant post-traumatic stress disorder.
MAPS is collaborating with Sunstone Therapies to conduct a clinical trial testing the safety and tolerability of MDMA-assisted therapy for patients with treatment-resistant post-traumatic stress disorder.
MAPS is collaborating with...
09/19/2022
Psych Congress Network
News
Added Brexpiprazole Improves Life Engagement in Adults With Major Depression
09/18/2022
Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.
Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.
Adjunctive brexpiprazole was...
09/18/2022
Psych Congress Network
News
Zuranolone Eases MDD for Majority of Study Participants, Interim Analysis Shows
09/18/2022
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase...
09/18/2022
Psych Congress Network

Advertisement

Podcasts
New Mechanisms of Action in Psychiatry With Dr Craig Chepke
09/14/2022
In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...
In this podcast excerpt, Craig Chepke, MD, FAPA, psychiatrist and medical director at Excel Psychiatric Associates in Huntersville, North Carolina, discusses the new mechanisms of action (MOAs) that could help to improve patient care in the...
In this podcast excerpt, Craig...
09/14/2022
Psych Congress Network
News
Targeting Anhedonia May Help Functioning in Patients With Schizophrenia
09/14/2022
Anhedonia appears to be a rational treatment target for improving global functioning in patients with schizophrenia, suggest study findings published online ahead of print in JAMA Psychiatry.
Anhedonia appears to be a rational treatment target for improving global functioning in patients with schizophrenia, suggest study findings published online ahead of print in JAMA Psychiatry.
Anhedonia appears to be a...
09/14/2022
Psych Congress Network
News
Severe Mental Illness Linked with Higher Odds of Multiple Chronic Conditions
09/13/2022
People with severe mental illness have elevated odds for a range of chronic physical health problems 5 years before through 5 years after their diagnosis of schizophrenia, bipolar disorder, or other psychotic illness, according to a study...
People with severe mental illness have elevated odds for a range of chronic physical health problems 5 years before through 5 years after their diagnosis of schizophrenia, bipolar disorder, or other psychotic illness, according to a study...
People with severe mental...
09/13/2022
Psych Congress Network

Advertisement

News
Vortioxetine Enhances Functioning in Real-World Outpatients with MDD
09/13/2022
Outpatients with major MDD treated with vortioxetine in real-world settings improve functioning.
Outpatients with major MDD treated with vortioxetine in real-world settings improve functioning.
Outpatients with major MDD...
09/13/2022
Psych Congress Network
News
Children May Be Especially Vulnerable to Disturbed Sleep, Depressive Symptoms Spirals
09/13/2022
Significant bidirectional associations and cascade processes between depressive symptoms and disturbed sleep occur in children through age 12.
Significant bidirectional associations and cascade processes between depressive symptoms and disturbed sleep occur in children through age 12.
Significant bidirectional...
09/13/2022
Psych Congress Network
News
Higher Activity Levels Linked to Lower Dementia Risk
09/12/2022
Staying active at older ages could help prevent dementia, regardless of genetic susceptibility, according to a study published in Neurology.
Staying active at older ages could help prevent dementia, regardless of genetic susceptibility, according to a study published in Neurology.
Staying active at older ages...
09/12/2022
Psych Congress Network

Advertisement

News
72 Genes With Very Strong Autism Associations Identified in Large-Scale Analysis
09/07/2022
A genetic analysis of more than 150,000 people has identified 72 genes very strongly associated with autism and more than 250 others with strong autism associations. Researchers published their findings online ahead of print in Nature...
A genetic analysis of more than 150,000 people has identified 72 genes very strongly associated with autism and more than 250 others with strong autism associations. Researchers published their findings online ahead of print in Nature...
A genetic analysis of more than...
09/07/2022
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use